Bab's Hobbs Pharma Guide

Tag: FDA

REMS for Isotretinoin: iPLEDGE Requirements and Safety in 2025
Justine Traver

REMS for Isotretinoin: iPLEDGE Requirements and Safety in 2025

iPLEDGE is the FDA's strict program to prevent birth defects from isotretinoin. Learn the 2025 requirements, recent changes, and how to navigate the system safely.

31 Dec 2025

Browse by category

  • Health & Wellness (155)

Latest news

  • Immunotherapy: How Checkpoint Inhibitors and CAR-T Cell Therapy Are Changing Cancer Treatment
  • Colesevelam GI Side Effects: How to Manage Constipation and Bloating
  • Ear Canal Infections and Mental Health: Anxiety, Sleep, Focus-What Helps
  • Dry Mouth and Bad Breath: Causes, Connections, and Real-Life Freshening Tips
  • Medication Reformulations: When Companies Change Drug Formulas

Posts Tags

  • medication safety
  • online pharmacy
  • drug interactions
  • side effects
  • medication reconciliation
  • generic medication
  • bioequivalence
  • medication errors
  • patient safety
  • dietary supplement
  • online pharmacy safety
  • patient communication
  • reemerging influenza
  • antihistamine side effects
  • diarrhea treatment
  • alternative treatments
  • pain management
  • medication side effects
  • targeted therapy
  • patent expiration
Bab's Hobbs Pharma Guide
Menu
  • About
  • Terms of Service
  • Privacy Policy
  • GDPR Compliance
  • Contact

© 2026. All rights reserved.